Hannan Edward L, Racz Michael J, Walford Gary, Jones Robert H, Ryan Thomas J, Bennett Edward, Culliford Alfred T, Isom O Wayne, Gold Jeffrey P, Rose Eric A
University at Albany, State University of New York, Albany, NY, USA.
N Engl J Med. 2005 May 26;352(21):2174-83. doi: 10.1056/NEJMoa040316.
Several studies have compared outcomes for coronary-artery bypass grafting (CABG) and percutaneous coronary intervention (PCI), but most were done before the availability of stenting, which has revolutionized the latter approach.
We used New York's cardiac registries to identify 37,212 patients with multivessel disease who underwent CABG and 22,102 patients with multivessel disease who underwent PCI from January 1, 1997, to December 31, 2000. We determined the rates of death and subsequent revascularization within three years after the procedure in various groups of patients according to the number of diseased vessels and the presence or absence of involvement of the left anterior descending coronary artery. The rates of adverse outcomes were adjusted by means of proportional-hazards methods to account for differences in patients' severity of illness before revascularization.
Risk-adjusted survival rates were significantly higher among patients who underwent CABG than among those who received a stent in all of the anatomical subgroups studied. For example, the adjusted hazard ratio for the long-term risk of death after CABG relative to stent implantation was 0.64 (95 percent confidence interval, 0.56 to 0.74) for patients with three-vessel disease with involvement of the proximal left anterior descending coronary artery and 0.76 (95 percent confidence interval, 0.60 to 0.96) for patients with two-vessel disease with involvement of the nonproximal left anterior descending coronary artery. Also, the three-year rates of revascularization were considerably higher in the stenting group than in the CABG group (7.8 percent vs. 0.3 percent for subsequent CABG and 27.3 percent vs. 4.6 percent for subsequent PCI).
For patients with two or more diseased coronary arteries, CABG is associated with higher adjusted rates of long-term survival than stenting.
多项研究比较了冠状动脉旁路移植术(CABG)和经皮冠状动脉介入治疗(PCI)的疗效,但大多数研究是在支架出现之前进行的,支架的出现彻底改变了后一种治疗方法。
我们利用纽约的心脏登记系统,确定了1997年1月1日至2000年12月31日期间接受CABG的37212例多支血管病变患者和接受PCI的22102例多支血管病变患者。我们根据病变血管数量以及左前降支冠状动脉是否受累,确定了不同患者组术后三年内的死亡率和再次血管重建率。采用比例风险法对不良结局发生率进行调整,以考虑血管重建术前患者疾病严重程度的差异。
在所有研究的解剖亚组中,接受CABG的患者经风险调整后的生存率显著高于接受支架置入的患者。例如,对于左前降支冠状动脉近端受累的三支血管病变患者,CABG术后长期死亡风险相对于支架置入的调整后风险比为0.64(95%置信区间为0.56至0.74);对于左前降支冠状动脉非近端受累的两支血管病变患者,该风险比为0.76(95%置信区间为0.60至0.96)。此外,支架置入组的三年再次血管重建率明显高于CABG组(再次CABG为7.8%对0.3%,再次PCI为27.3%对4.6%)。
对于有两支或更多支病变冠状动脉的患者,CABG与比支架置入更高的调整后长期生存率相关。